Your browser doesn't support javascript.
loading
A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept, and Laser for Retinopathy of Prematurity.
Chang, Emer; Josan, Amandeep S; Purohit, Ravi; Patel, Chetan K; Xue, Kanmin.
Afiliación
  • Chang E; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Josan AS; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Purohit R; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Patel CK; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Ophthalmology Department, Great Ormond Street Hospital for Children National Health Service Foundation Trust, London, United Kingdom.
  • Xue K; Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom. Electronic address: enquiries@eye.ox.ac.uk.
Ophthalmology ; 129(12): 1389-1401, 2022 12.
Article en En | MEDLINE | ID: mdl-35842190
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Ranibizumab Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans / Newborn Idioma: En Revista: Ophthalmology Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Retinopatía de la Prematuridad / Ranibizumab Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans / Newborn Idioma: En Revista: Ophthalmology Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos